1887
Surveillance Open Access
Like 0

Abstract

Background

Between 2020 and 2023, ECDC has supported 21 of 30 EU/EEA and six Western Balkan countries by enhancing severe acute respiratory infection (SARI) surveillance to monitor trends, detect unexpected events, evaluate public health interventions, identify risk factors and support vaccine effectiveness studies. Using diverse strategies, countries have implemented SARI surveillance and reported data at national/European levels.

Aim

We evaluated European-level SARI surveillance and provided recommendations to achieve objectives and improve key attribute performance.

Methods

We analysed 2022/23 surveillance data for completeness. We administered a questionnaire, targeting country-level representatives, to evaluate surveillance attributes (meeting objectives, usefulness, acceptability, timeliness, representativeness) and identify strengths, weaknesses, opportunities and threats.

Results

Thirteen countries (13/27) reported data at European level. Data showed good overall completeness but varied across countries and some variables need improvement (vaccination, sequencing). The questionnaire was completed by all 27 countries. Most countries (23/27) reported that the system effectively monitored trends and considered it useful and acceptable (25/27), but only 16 found it timely and 14 representative. Challenges included insufficient case-based data, data linkage issues and insufficient data completeness. Slow/inefficient manual data extraction affected timeliness, while insufficient geographical coverage affected representativeness. Multi-pathogen surveillance was identified as the main strength, heterogeneity of systems the main weakness, improvements of hospital information systems the main opportunity, and lack of sustainable funding the main threat.

Conclusions

SARI surveillance was perceived as effective in monitoring trends, useful and acceptable. To achieve additional objectives and enhance timeliness and representativeness, we recommend improving data completeness, digitalisation/automation and geographical coverage.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2025.30.20.2400655
2025-05-22
2025-05-24
/content/10.2807/1560-7917.ES.2025.30.20.2400655
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/30/20/eurosurv-30-20-5.html?itemId=/content/10.2807/1560-7917.ES.2025.30.20.2400655&mimeType=html&fmt=ahah

References

  1. Torres AR, Silva S, Kislaya I, Martins JP, Matias Dias C, Rodrigues AP. [Early detection of COVID-19 in Portugal: use of clinical records]. Acta Med Port. 2021;34(3):176-84.  https://doi.org/10.20344/amp.14593  PMID: 33971114 
  2. Ziemann A, Rosenkötter N, Riesgo LGC, Fischer M, Krämer A, Lippert FK, et al. Meeting the International Health Regulations (2005) surveillance core capacity requirements at the subnational level in Europe: the added value of syndromic surveillance. BMC Public Health. 2015;15(1):107.  https://doi.org/10.1186/s12889-015-1421-2  PMID: 25879869 
  3. Tolksdorf K, Haas W, Schuler E, Wieler LH, Schilling J, Hamouda O, et al. ICD-10 based syndromic surveillance enables robust estimation of burden of severe COVID-19 requiring hospitalization and intensive care treatment. medRxiv; 2022. Preprint. https://www.medrxiv.org/content/10.1101/2022.02.11.22269594v2 https://doi.org/10.1101/2022.02.11.22269594 
  4. World Health Organization (WHO). Global epidemiological surveillance standards for influenza. Geneva: WHO; 2013. Available from: https://apps.who.int/iris/handle/10665/311268
  5. Marbus SD, van der Hoek W, van Dissel JT, van Gageldonk-Lafeber AB. Experience of establishing severe acute respiratory surveillance in the Netherlands: Evaluation and challenges. Public Health Pract (Oxf). 2020;1:100014.  https://doi.org/10.1016/j.puhip.2020.100014  PMID: 34171043 
  6. Beauté J. Evaluation of severe influenza surveillance in Europe. ECDC: Stockholm; 2014. Available from: https://www.slideshare.net/slideshow/evaluation-of-severe-influenza-surveillance-in-europe/36992553
  7. Bagaria J, Jansen T, Marques DF, Hooiveld M, McMenamin J, de Lusignan S, et al. Rapidly adapting primary care sentinel surveillance across seven countries in Europe for COVID-19 in the first half of 2020: strengths, challenges, and lessons learned. Euro Surveill. 2022;27(26):2100864.  https://doi.org/10.2807/1560-7917.ES.2022.27.26.2100864  PMID: 35775429 
  8. World Health Organisation Regional Office for Europe and European Centre for Disease Prevention and Control (WHO/Europe and ECDC). Operational considerations for respiratory virus surveillance in Europe. Copenhagen and Stockholm: WHO/Europe and ECDC; 2022. Available from: https://www.ecdc.europa.eu/en/publications-data/operational-considerations-respiratory-virus-surveillance-europe
  9. European Centre for Disease Prevention and Control (ECDC). Vaccine Effectiveness, Burden and Impact Studies (VEBIS). Stockholm: ECDC; 2023. Available from: https://www.ecdc.europa.eu/en/infectious-disease-topics/related-public-health-topics/immunisation-and-vaccines/vaccine-0
  10. European Centre for Disease Prevention and Control (ECDC). ECDC accession support to the Western Balkans and Türkiye. Stockholm: ECDC; 2023. Available from: https://www.ecdc.europa.eu/en/about-ecdc/what-we-do/partners-and-networks/international-cooperation/cooperation-western-balkans-turkiye
  11. EU Funding and Tenders Portal. Design and Implementation of multinational surveillance systems using routinely collected electronic health records in EU/EEA - OJ/2021/PHF/12625. Brussels; European Commission. [Accessed: 5 Feb 2025]. Available from: https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/tender-details/9819
  12. Fitzner J, Qasmieh S, Mounts AW, Alexander B, Besselaar T, Briand S, et al. Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection. Bull World Health Organ. 2018;96(2):122-8.  https://doi.org/10.2471/BLT.17.194514  PMID: 29403115 
  13. European Centre for Disease Prevention and Control (ECDC). Severe Acute Respiratory Infections (SARI) reporting protocol version 3.8. Stockholm: ECDC; 2023. Available from: https://www.ecdc.europa.eu/en/publications-data/severe-acute-respiratory-infections-sari-reporting-protocol
  14. European Centre for Disease Prevention and Control (ECDC). European Respiratory Virus Surveillance Summary (ERVISS) dashboard. Stockholm: ECDC. [Accessed: 18 Sep 2024]. Available from: https://erviss.org
  15. Brady M, Duffy R, Domegan L, Salmon A, Maharjan B, O’Broin C, et al. Establishing severe acute respiratory infection (SARI) surveillance in a sentinel hospital, Ireland, 2021 to 2022. Euro Surveill. 2023;28(23):2200740.  https://doi.org/10.2807/1560-7917.ES.2023.28.23.2200740  PMID: 37289427 
  16. Buda S, Tolksdorf K, Schuler E, Kuhlen R, Haas W. Establishing an ICD-10 code based SARI-surveillance in Germany - description of the system and first results from five recent influenza seasons. BMC Public Health. 2017;17(1):612.  https://doi.org/10.1186/s12889-017-4515-1  PMID: 28666433 
  17. Cauchi JP, Borg ML, Džiugytė A, Attard J, Melillo T, Zahra G, et al. Digitalizing and upgrading severe acute respiratory infections surveillance in Malta: system development. JMIR Public Health Surveill. 2022;8(12):e37669.  https://doi.org/10.2196/37669  PMID: 36227157 
  18. Torres AR, Gómez V, Kislaya I, Rodrigues AP, Fernandes Tavares M, Pereira AC, et al. Monitoring COVID-19 and influenza: the added value of a severe acute respiratory infection surveillance system in Portugal. Can J Infect Dis Med Microbiol. 2023;2023:6590011.  https://doi.org/10.1155/2023/6590011  PMID: 36846348 
  19. Wells J, Young JJ, Harvey C, Mutch H, McPhail D, Young N, et al. Real-time surveillance of severe acute respiratory infections in Scottish hospitals: an electronic register-based approach, 2017-2022. Public Health. 2022;213:5-11.  https://doi.org/10.1016/j.puhe.2022.09.003  PMID: 36306639 
  20. El-Khatib Z, Richter L, Reich A, Benka B, Assadian O. Implementation of a surveillance system for severe acute respiratory infections at a tertiary care hospital in Austria: protocol for a retrospective longitudinal feasibility study. JMIR Res Protoc. 2023;12:e47547.  https://doi.org/10.2196/47547  PMID: 37535414 
  21. European Centre for Disease Prevention and Control (ECDC). Data quality monitoring and surveillance system evaluation - A handbook of methods and applications. Stockholm: ECDC; 2014. Available from: https://www.ecdc.europa.eu/en/publications-data/data-quality-monitoring-and-surveillance-system-evaluation-handbook-methods-and
  22. Arkema A, Paget J, Meijer A, Meerhoff T, Velden K van der, Faassen A. European Influenza Surveillance Scheme (EISS) annual report: 2006-2007 influenza season. Utrecht: Nivel; 2008. Available from: https://www.nivel.nl/en/publicatie/european-influenza-surveillance-scheme-eiss-annual-report-2006-2007-influenza-season
  23. Young JJ, Mutch H, Rose AMC, Evans JMM, McMenamin J, Murray J, et al. Enhanced surveillance of hospitalized COVID-19 patients in Europe: an evaluation of the I-MOVE-COVID-19 surveillance network. Eur J Public Health. 2024;34(1):181-9.  https://doi.org/10.1093/eurpub/ckad185  PMID: 37889597 
  24. Centers for Disease Control and Prevention (CDC). Updated guidelines for evaluating public health surveillance systems. Atlanta: CDC; 2001. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5013a1.htm
  25. European Centre for Disease Prevention and Control (ECDC). The European Surveillance System (TESSy). [Accessed: 18 Sep 2024]. Available from: https://www.ecdc.europa.eu/en/publications-data/european-surveillance-system-tessy
  26. European Centre for Disease Prevention and Control (ECDC). Severe influenza surveillance in Europe. Stockholm: ECDC; 2012. Available from: https://www.ecdc.europa.eu/en/publications-data/severe-influenza-surveillance-europe
  27. European Centre for Disease Prevention and Control (ECDC). Intensified circulation of respiratory syncytial virus (RSV) and associated hospital burden in the EU/EEA. Stockholm: ECDC; 2022. Available from: https://www.ecdc.europa.eu/en/publications-data/intensified-circulation-respiratory-syncytial-virus-rsv-and-associated-hospital
  28. Antunes L, Mazagatos C, Martínez-Baz I, Gomez V, Borg ML, Petrović G, et al. Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023. Euro Surveill. 2024;29(3):2300708.  https://doi.org/10.2807/1560-7917.ES.2024.29.3.2300708  PMID: 38240061 
  29. Seppälä E, Bøås H, Dahl J, Stålcrantz J, Stecher M, Tønnessen R, et al. Registry-based surveillance of severe acute respiratory infections in Norway during 2021-2024. Influenza Other Respir Viruses. 2025;19(2):e70080.  https://doi.org/10.1111/irv.70080  PMID: 39950571 
  30. Marron L, Duffy R, O’Donnell J, Domegan L. An evaluation of the severe acute respiratory infection surveillance system in Ireland. BMC Public Health. 2025;25(1):492.  https://doi.org/10.1186/s12889-025-21645-3  PMID: 39915743 
/content/10.2807/1560-7917.ES.2025.30.20.2400655
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error